Australia markets closed

PMV Pharmaceuticals, Inc. (PMVP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.6700-0.0600 (-3.47%)
At close: 04:00PM EST
1.6700 0.00 (0.00%)
After hours: 08:00PM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
57,528
51,988
36,493
23,933
Selling general and administrative
24,864
25,052
21,800
11,009
Total operating expenses
82,392
77,040
58,293
34,942
Operating income or loss
-82,392
-77,040
-58,293
-34,942
Total other income/expenses net
44
87
21
-143
Income before tax
-72,546
-73,326
-57,823
-34,434
Income tax expense
3
-9
23
6
Income from continuing operations
-72,549
-73,317
-57,846
-34,440
Net income
-72,549
-73,317
-57,846
-34,440
Net income available to common shareholders
-72,549
-73,317
-57,846
-34,440
Basic EPS
-1.56
-1.61
-1.28
-2.40
Diluted EPS
-1.56
-1.61
-1.28
-2.40
Basic average shares
46,595
45,595
45,138
14,364
Diluted average shares
46,595
45,595
45,138
14,364